Reimagine a New Instron Way

Tissue Engineering & Regenerative Medicine

Learn about bioreactors

Take the Survey

How well do you know Instron® TERM?We want to know.

Take the Survey

Introduction to Tissue Engineering & Regenerative (TERM) Applications

Replacing body parts is one of mankind's earliest aims, as patients and healers have attempted to cope with disabilities.  Tissue Engineering & Regenerative Medicine are dedicated to creating new tissue engineered medical devices that replace and/or enhance tissue function that has been impaired by disease, injury, or age. Because these are expansive fields that incorporate a myriad of disciplines, definitions for each term can be confusing.


Tissue Engineering is the combination of cells, scaffolds (material on which to grow the cells), and an appropriate biological, chemical, and mechanical environment to grow or build 3D tissues which are similar to native tissue. Researchers in this field are interested in characterizing the native tissue and environment, identifying the appropriate recipe to grow new tissue, and evaluating the results of tissue engineering efforts. Tissue engineered products can be used as benchtop models of in vivo environments, to study disease and the effects of new therapies (pharmaceuticals), or in regenerative medicine applications.


Regenerative Medicine is the application of these tissue engineered medical products as a clinical therapy. This field includes not only the tissue engineered medical device, but also the patients, health care providers, and associated clinical therapies necessary to integrate these services and products to improve health care options.

Learn More


Ex vivo research is a rapidly developing area with the potential to significantly impact a wide range of biomedical applications. Instron TERM employs experts in mechanical, electrical, software and biomedical engineering to develop bioreactors so you don't have to.

Learn About Our Applications


Our mission is to provide technologically advanced bioreactor solutions for creating new tissue engineered medical devices and clinically relevant therapies. We also strive to define the standard for tissue growth devices and instrumentation. This philosophy permeates the design and fabrication of each Instron TERM system.

Learn About Our Products


Our chambers carry a variety of critical features for tissue growth and 3-D culture. Our bioreactor chambers are third generation designs, and capture the benefits of customer feedback.

Learn About Our Chambers


Did you know that Instron has a wide range of products for Tissue Engineering and Regenerative Medicine (TERM) Applications? Our innovative material testing technology is the most comprehensive commercial solution for the TERM market! We are proud to present Instron TERM.



  • Children's Mercy Hospital and Clinics
  • Cook Biotech
  • Drexel University
  • FDA Center for Devices and Radiological Health
  • Gel-Del Technologies
See Full List


  • The Challenges of Tissue Characterization

    The Challenges of Tissue Characterization TERM research is poised to change the way we know health care. This cutting-edge technology demands new tools and solutions that are able to keep up with the development in personalized medicine. Instron® is delivering those solutions.

    More Info
  • As Featured in Quality Magazine

    All parties recognize the importance of developing test standards and providing the est possible medical devices, but determining the best methods is a challenge.

    More Info
  • Instron TERM - Video

    See the magic of Instron TERM characterize tissue and culture cells.

    More Info
  • Biomedical Advances

    Instron TERM's quarterly newsletter is focused on research and product development challenges in the tissue engineering and regenerative medicine field. Topics include new customer applications, new Instron products, and technology innovation updates.

    More Info
  • Instron TERM sponsors ISACB Webinar Series

    Register today for the Winter 2015 Webinar on February 5, 2015. "Stem Cell Therapy for Cardiovascular Disease: From Cell to Heart" Robert Deans, PhD & Keith March, MD, PhD

    More Info
Instron TERM — 825 University Ave, Norwood, MA 02062
781-575-5003 |
Copyright © 2014 Instron TERM. All Rights Reserved. Instron aquired Tissue Growth Technologies (TGT)